Holen Sie sich die Stockscreener-App
7.745
9.80%
0.705
Schlusskurs vom Vortag:
$7.04
Offen:
$7.07
24-Stunden-Volumen:
345.87K
Relative Volume:
1.38
Marktkapitalisierung:
$208.38M
Einnahmen:
$331.52M
Nettoeinkommen (Verlust:
$-52.69M
KGV:
-3.4422
EPS:
-2.25
Netto-Cashflow:
$-14.47M
1W Leistung:
+22.12%
1M Leistung:
+11.71%
6M Leistung:
-23.77%
1J Leistung:
-34.44%
1-Tages-Spanne:
$7.00
$7.76
1-Wochen-Bereich:
$5.8502
$7.75
52-Wochen-Spanne:
$5.70
$13.33
Inogen Inc Stock (INGN) Company Profile
Firmenname
Inogen Inc
Sektor
Branche
Telefon
805-562-0500
Adresse
859 WARD DRIVE, GOLETA, CA
Vergleichen Sie INGN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
INGN
Inogen Inc
|
7.75 | 174.23M | 331.52M | -52.69M | -14.47M | -2.25 |
|
ABT
Abbott Laboratories
|
130.54 | 233.71B | 43.11B | 13.98B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
102.14 | 152.83B | 18.49B | 2.51B | 3.23B | 1.68 |
|
SYK
Stryker Corp
|
375.62 | 144.35B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
91.75 | 119.00B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
76.97 | 46.00B | 5.69B | 4.14B | 577.90M | 6.96 |
Inogen Inc Stock (INGN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-06-16 | Eingeleitet | B. Riley Securities | Buy |
| 2025-05-22 | Hochstufung | Needham | Hold → Buy |
| 2024-02-15 | Hochstufung | William Blair | Mkt Perform → Outperform |
| 2023-08-08 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2023-07-14 | Herabstufung | Needham | Buy → Hold |
| 2023-01-17 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2021-12-09 | Hochstufung | Needham | Hold → Buy |
| 2021-11-02 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2021-08-05 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2021-06-04 | Hochstufung | William Blair | Mkt Perform → Outperform |
| 2020-12-14 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2020-07-23 | Herabstufung | Needham | Buy → Hold |
| 2020-05-06 | Bestätigt | Needham | Buy |
| 2019-11-06 | Hochstufung | Needham | Hold → Buy |
| 2019-09-13 | Bestätigt | Piper Jaffray | Overweight |
| 2019-08-08 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2019-08-08 | Herabstufung | Stifel | Buy → Hold |
| 2019-08-07 | Herabstufung | Needham | Buy → Hold |
| 2019-06-28 | Herabstufung | Needham | Strong Buy → Buy |
| 2019-05-08 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2019-05-08 | Bestätigt | Needham | Strong Buy |
| 2019-02-27 | Bestätigt | Needham | Strong Buy |
| 2018-11-20 | Hochstufung | Needham | Buy → Strong Buy |
| 2018-11-07 | Bestätigt | Needham | Buy |
| 2018-09-10 | Herabstufung | Needham | Strong Buy → Buy |
| 2018-08-22 | Fortgesetzt | Stifel | Buy |
| 2018-08-08 | Bestätigt | Needham | Strong Buy |
| 2018-06-06 | Eingeleitet | KeyBanc Capital Mkts | Sector Weight |
| 2018-05-01 | Bestätigt | Needham | Strong Buy |
| 2018-02-28 | Bestätigt | Needham | Strong Buy |
Alle ansehen
Inogen Inc Aktie (INGN) Neueste Nachrichten
Tools to assess Inogen Inc.’s risk profileChart Based Entry Tool for ROI Traders - Newser
Inogen, Inc. (NASDAQ:INGN) Q2 2025 Earnings Call Transcript - Insider Monkey
Inogen Inc. stock prediction for this weekAlpha Generation Strategy with Low Volatility - Newser
US Durable Medical Equipment Market Forecast and Competitive Landscape Report 2025-2033 | Invacare, NOVA, Inogen, Thermo Fisher Scientific, Abbott, Medtronic, Baxter, B. Braun, Boston Scientific, BD - uk.finance.yahoo.com
How to build a custom watchlist for Inogen Inc.Short Term Gain Strategy with AI Logic - Newser
Why Inogen Inc. stock attracts strong analyst attentionFree Accurate Buy Point for Momentum Stocks - Newser
How Interest Rate Changes Impact Inogen Inc. Stock PerformanceMachine Learning Stock Price Forecast Tool - Newser
Statistical indicators supporting Inogen Inc.’s strengthFree Daily Chart Pattern Stock Forecast - Newser
Is now a turning point for Inogen Inc.Forecasting Stock Moves with AI Insights - Newser
What indicators show strength in Inogen Inc.Free Buy Alerts With Low Risk Confirmation - Newser
Inogen Second Quarter 2025 Earnings: Beats Expectations - ca.finance.yahoo.com
Live market analysis of Inogen Inc.Chart Driven Opportunity Scanner with Alerts - Newser
Inogen's Q2 Earnings Beat: A Glimpse of Strategic Turnaround Amid Industry Headwinds? - AInvest
Inogen Stock Gains Following Q2 Earnings Beat, Revenues Up Y/Y - MSN
Inogen's Q2 2025 Earnings and Strategic Product Innovation: A Pathway to Margin Expansion and Market Leadership - AInvest
Inogen (INGN) Reports Q2 Loss, Beats Revenue Estimates - NewsBreak: Local News & Alerts
How Inogen Inc. stock performs during market volatilityCapital Growth Summary Over Five Years - Newser
Can Inogen Catch Its Second Breath After An Upbeat Outlook? - RTTNews
Inogen: Q2 Earnings Snapshot - Connecticut Post
Inogen Q2 2025 slides: B2B growth offsets consumer segment decline By Investing.com - Investing.com South Africa
Inogen Inc (INGN) Q2 2025 Earnings Call Highlights: Steady Growth Amidst Challenges - Yahoo Finance
Predicting Inogen Inc. trend using moving averagesFree Access to Real-Time Trade Insights - Newser
Inogen Inc (INGN) Q2 2025 Earnings Call Highlights: Steady Growth Amidst Challenges By GuruFocus - Investing.com Canada
Inogen Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Inogen reports Q2 EPS (15c), one estimate (9c) - TipRanks
What’s next for Inogen Inc. stock priceHistorical Stock Summary and ROI Review - Newser
Inogen's Turnaround Momentum and Path to EBITDA Breakeven in 2025 - AInvest
Inogen Inc earnings beat by $0.12, revenue topped estimates - Investing.com South Africa
Inogen Q2 revenue up 4%, beats estimates, raises FY revenue guidance - MarketScreener
Inogen Announces Second Quarter 2025 Financial Results - Yahoo Finance
Inogen Inc expected to post a loss of 27 cents a shareEarnings Preview - TradingView
Will Inogen Inc. stock recover after recent dropLong Hold Investment Strategy with Growth Focus - Newser
Finanzdaten der Inogen Inc-Aktie (INGN)
Umsatz
Nettogewinn
Free Cashflow
ENV
Inogen Inc-Aktie (INGN) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Bourque Michael J. | EVP, CFO & Treasurer |
Mar 03 '25 |
Buy |
8.32 |
3,000 |
24,960 |
47,646 |
| Smith Kevin Raymond Merrill | CEO and President |
Mar 01 '25 |
Option Exercise |
0.00 |
28,333 |
0 |
44,387 |
| Smith Kevin Raymond Merrill | CEO and President |
Mar 03 '25 |
Buy |
8.56 |
11,709 |
100,245 |
70,274 |
| Smith Kevin Raymond Merrill | CEO and President |
Dec 01 '24 |
Option Exercise |
0.00 |
28,333 |
0 |
28,333 |
| Ramade Gregoire | Chief Commercial Officer |
Dec 01 '24 |
Option Exercise |
0.00 |
31,565 |
0 |
31,565 |
0.31%
0.62%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):